UNSPSC 51342602: Fomivirsen

This classification denotes an antisense agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3Z6W3S36X5. European Medicines Agency schedules Fomivirsen sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02253MIG. Fomivirsen sodium generally arises in the molecular formula C204H243N63O114P20S20.20NA. The term FOMIVIRSEN SODIUM is a United States Adopted Name designation. Most nations schedule fomivirsen under HS 29349990 and SITC 51579.

As of Q4 2014, FOMIVIRSEN remains the US FDA Preferred Term for this commodity.

UNSPSC 51342602 Fomivirsen is a Commodity code that captures pharmaceutical and medical supply procurement by state and local health agencies, though recent activity under this code reflects a broader mix of pharmaceutical, naloxone, and medical-supply acquisitions rather than the fomivirsen antiviral alone. State and local governments are buying generic pharmaceuticals, over-the-counter products, naloxone and drug-deactivation systems, and emergency medical supplies through this code. Issuing bodies include state health departments and agencies (Texas Health and Human Services Commission, Minnesota Department of Administration), county health systems (Seminole County, Florida), municipal fire and rescue divisions (City of Tampa Fire Department), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities across multiple states including Oregon). The Tennessee Health and Human Services Commission, Texas HHS, and MMCAP appear as repeat or large-scale buyers for pharmaceutical and OTC products through cooperative purchasing vehicles and direct-to-manufacturer initiatives.

Recent opportunities span the upper Midwest and Southeast. Minnesota's MMCAP RFP (S1070000015802, due March 26, 2026) sought generic multi-source pharmaceuticals and OTC products for state and local facilities across participating jurisdictions, requiring manufacturers to supply through three authorized wholesalers with pricing evaluated at 75 percent weight on competitiveness. Seminole County, Florida's IFB 60459723LAS (due July 26, 2023) procured 1,900 units of naloxone and 800 safe drug-deactivation systems annually through quarterly deliveries, with a two-year initial term and one-year renewal option. The City of Tampa's ITB 26-P-00145 (due March 13, 2026) sought 169 line items of medical and first aid supplies for the Fire Department Rescue Division, estimated at $700,000.00 and designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. Texas HHS issued an RFI (HHS0017013, due April 3, 2026) to gather market intelligence on direct-to-manufacturer prescription programs and vendor capabilities for direct contracting outside traditional pharmacy benefit manager arrangements.